BRISTAGEN Trademark

Trademark Overview


On Monday, September 15, 1980, a trademark application was filed for BRISTAGEN with the United States Patent and Trademark Office. The USPTO has given the BRISTAGEN trademark a serial number of 73277918. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 9, 1989. This trademark is owned by Bristol-Myers Company. The BRISTAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Antibiotic

General Information


Serial Number73277918
Word MarkBRISTAGEN
Filing DateMonday, September 15, 1980
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 9, 1989
Registration Number1189717
Registration DateTuesday, February 16, 1982
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 24, 1981

Trademark Statements


Goods and ServicesAntibiotic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 1989
Primary Code005
First Use Anywhere DateFriday, August 8, 1980
First Use In Commerce DateFriday, August 8, 1980

Trademark Owner History


Party NameBristol-Myers Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Party NameBristol-Myers Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Party NameBristol-Myers Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Friday, June 9, 1989CANCELLED SEC. 8 (6-YR)
Tuesday, February 16, 1982REGISTERED-PRINCIPAL REGISTER
Tuesday, November 24, 1981PUBLISHED FOR OPPOSITION

Related Keywords


bristagen antibiotic